To Predict Weight Loss Response to Liraglutide (Saxenda®), from fMRI-based Determination of Food Cue Reactivity

Project Details

StatusActive
Effective start/end date06/1/18 → …

Funding

  • Novo Nordisk-Private: $472,446.00

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.